Orient Precision Industries Q1 2026 consolidated operating loss, net loss widened

Consolidated revenue 37.5B KRW (-9.4% YoY), operating loss 0.6B KRW (vs profit 2.0B), net loss 24.9B KRW (vs profit 2.0B)
Basic EPS loss 78 KRW (vs profit 6 KRW)
Debt ratio 159% (up from 148% year-end), total borrowings 34.5B KRW (year-end 27.7B)
Cash 1.5B KRW (down from 3.3B year-end)
Capital increase: 1.5M new shares, capital stock 16.6B KRW
Related party receivables surged to 18.3B KRW (year-end 5.0B), including 14.5B for asset acquisition from Orient Electronics
Loss on disposal of entire stake in Orient Bio: 1.9B KRW
New borrowings 5.8B KRW (from NobusPharm) and prepayments 16.0B KRW worsened cash flow